The Health Research Extension Act of 1985 re-establishes the National Institutes of Health (NIH) as an agency of the Public Health Service, consisting of 12 categorical institutes focused on various health issues such as cancer, heart, lung, and blood diseases, diabetes, and more. It authorizes the Secretary of Health and Human Services to create additional research institutes and reorganize existing ones. The Act outlines responsibilities for the NIH Director and institute directors, including reporting and advisory duties, and allows for research grants and contracts. It emphasizes research in specific areas like cancer, heart and lung diseases, diabetes, and arthritis, and sets up advisory boards and committees to guide research efforts. The Act also includes provisions for the ethical conduct of research, animal research standards, and expedited grant procedures in public health emergencies.
Media coverage of the Health Research Extension Act of 1985 has generally been positive, highlighting its comprehensive approach to consolidating and expanding the NIH's role in health research. The Act is praised for its focus on establishing clear guidelines for research priorities and funding, as well as its emphasis on ethical standards in biomedical research. Commentators have noted the importance of the Act in fostering collaboration between American and international researchers, and its potential to advance understanding and treatment of major health issues.
Criticism of the Health Research Extension Act of 1985 primarily centers on concerns about bureaucratic expansion and potential inefficiencies within the NIH. Some media outlets have raised issues about the complexity of the Act and the potential for overlap and duplication of efforts among the various institutes and advisory boards. Additionally, there are concerns about the adequacy of funding to meet the ambitious goals set forth in the Act, and whether the NIH can effectively manage the broad scope of responsibilities assigned to it.
Based on the available data, there appears to be a low risk of conflicts of interest between the sponsor's donors and the bill's subject matter. The sponsor, Henry Waxman, has received significant donations from the Retired, Securities & Investment, and Government industries. However, none of these industries directly overlap with the subject matter of the Health Research Extension Act of 1985. Furthermore, the lobbying activity related to this bill's policy area does not involve any of the sponsor's top donor industries. The largest lobbying expenditure was made by the Association of American Railroads, which spent $1,413,000. However, this organization does not appear to have any direct connection to the sponsor's top donors. Therefore, based on the available data, there is no clear money trail that would suggest a potential conflict of interest.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| RECORDING INDUSTRY ASSOCIATION OF AMERICA | RECORDING INDUSTRY ASSOCIATION OF AMERICA | $2,230,369 |
| ASSOCIATION OF AMERICAN RAILROADS | ASSOCIATION OF AMERICAN RAILROADS | $1,413,000 |
| AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | $620,000 |
| AE INDUSTRIAL PARTNERS, LP | AE INDUSTRIAL PARTNERS, LP | $270,000 |
| AMERICAN SOCIETY OF ANESTHESIOLOGISTS | AMERICAN SOCIETY OF ANESTHESIOLOGISTS | $219,480 |
| MEAT INSTITUTE (FKA NORTH AMERICAN MEAT INSTITUTE) | MEAT INSTITUTE (FKA NORTH AMERICAN MEAT INSTITUTE) | $130,000 |
| I AM ALS | I AM ALS | $30,000 |
| AMERICAN SECURITY FUND | ALLEGIANCE STRATEGIES, LLC | $30,000 |
| AMERICAN UNITY FUND, INC. | ALLEGIANCE STRATEGIES, LLC | $30,000 |
| SANTO DOMINGO PUEBLO | TELEGRAPH AVENUE ADVISORS | $20,000 |
| AMERICAN SOCIETY OF HUMAN GENETICS | LEWIS-BURKE ASSOCIATES, LLC | $10,000 |
| SPECIALTY EQUIPMENT MARKET ASSOCIATION | TELEGRAPH AVENUE ADVISORS | $10,000 |
| JOHN WILEY & SONS | ACCESS PARTNERSHIP CORP | undisclosed |
| RUTGERS - THE STATE UNIVERSITY OF NEW JERSEY | LEWIS-BURKE ASSOCIATES, LLC | undisclosed |
| MATRA GRUPA D.O.O. | TELEGRAPH AVENUE ADVISORS | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Henry Waxman, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
